We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00999336
Recruitment Status : Completed
First Posted : October 21, 2009
Last Update Posted : September 27, 2010
Merck Sharp & Dohme Corp.
Information provided by:
Portola Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2010
  Study Completion Date : February 2010